Haishan Wang

N. Sharif, A. Mitra, Haishan Wang, 2017, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.

SB939, a Novel Potent and Orally Active Histone Deacetylase Inhibitor with High Tumor Exposure and Efficacy in Mouse Models of Colorectal Cancer

Z. Bonday, J. Wood, Haishan Wang, 2010, Molecular Cancer Therapeutics.

Discovery of Kinase Spectrum Selective Macrocycle

J. Wood, A. Poulsen, Meredith Williams, 2011 .

Editor’s Highlight: Transgenic Zebrafish Reporter Lines as Alternative In Vivo Organ Toxicity Models

Sinnakaruppan Mathavan, P. Ingham, Haishan Wang, 2017, Toxicological sciences : an official journal of the Society of Toxicology.

Cloning, Exogenous Expression and Function Analysis of Interferon–γ from Gadus macrocephalus

Haishan Wang, Y. Mao, Jie Gu, 2022, Viruses.

New patented histone deacetylase inhibitors

Haishan Wang, B. Dymock, Brian W Dymock, 2009, Expert opinion on therapeutic patents.

Structure-based design of nitrogen-linked macrocyclic kinase inhibitors leading to the clinical candidate SB1317/TG02, a potent inhibitor of cyclin dependant kinases (CDKs), Janus kinase 2 (JAK2), and Fms-like tyrosine kinase-3 (FLT3)

A. Poulsen, Meredith Williams, H. Nagaraj, 2012, Journal of Molecular Modeling.

Antibody neutralization of microbiota-derived circulating peptidoglycan dampens inflammation and ameliorates autoimmunity

M. Oosting, L. Joosten, M. Netea, 2019, Nature Microbiology.

Structure and Ligand-Based Design of mTOR and PI3-Kinase Inhibitors Leading to the Clinical Candidates VS-5584 (SB2343) and SB2602

Anders Poulsen, Stéphanie Blanchard, Angeline Lee, 2014, J. Chem. Inf. Model..

Total Synthesis of the Cytotoxic Alkaloid Luotonin A.

A. Ganesan, Haishan Wang, 1999 .

416 The oral HDAC inhibitor SB939 shows activity in in vitro and in vivo models of acute myeloid leukemia

J. Wood, Haishan Wang, K. Goh, 2010 .

Isolation of streptonigrin and its novel derivative from Micromonospora as inducing agents of p53-dependent cell apoptosis.

M. Sim, Haishan Wang, J. Xu, 2002, Journal of natural products.

Structure-based design of oxygen-linked macrocyclic kinase inhibitors: discovery of SB1518 and SB1578, potent inhibitors of Janus kinase 2 (JAK2) and Fms-like tyrosine kinase-3 (FLT3)

Anders Poulsen, Anthony William, Stéphanie Blanchard, 2012, Journal of Computer-Aided Molecular Design.

Design, Synthesis, and Preclinical Evaluation of Fused Pyrimidine-Based Hydroxamates for the Treatment of Hepatocellular Carcinoma.

Chang Kai Soh, Haishan Wang, W. H. Goh, 2018, Journal of medicinal chemistry.

Structure-based design of PDK1 inhibitors.

Chang Kai Soh, A. Poulsen, Meredith Williams, 2012, Bioorganic & medicinal chemistry letters.

Synthesis and biological evaluation of 6-phenylpurine linked hydroxamates as novel histone deacetylase inhibitors.

Chang Kai Soh, Haishan Wang, W. H. Goh, 2020, Bioorganic chemistry.

nonaene ( SB 1578 ) , a Potent Inhibitor of Janus Kinase 2 / Fms-LikeTyrosine Kinase-3 ( JAK 2 / FLT 3 ) for the Treatment of Rheumatoid Arthritis

Anders Poulsen, Harish Nagaraj, Evelyn Tan, 2012 .

N-Hydroxy-1,2-disubstituted-1H-benzimidazol-5-yl acrylamides as novel histone deacetylase inhibitors: design, synthesis, SAR studies, and in vivo antitumor activity.

Z. Bonday, Haishan Wang, Xukun Wang, 2009, Bioorganic & medicinal chemistry letters.

Inhibitors of neutrophil recruitment identified using transgenic zebrafish to screen a natural product library

P. Ingham, Haishan Wang, M. Everett, 2013, Disease Models & Mechanisms.

SB939, a Novel Potent and Orally Active Histone Deacetylase Inhibitor with High Tumor Exposure and Efficacy in Mouse Models of Colorectal Cancer

J. Wood, Haishan Wang, S. Pettersson, 2010, Molecular Cancer Therapeutics.

162 POSTER Pharmacological profile of SB939, a novel, potent and orally active histone deacetylase inhibitor

J. Wood, Haishan Wang, K. Sangthongpitag, 2006 .